- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Nuclear medicine procedures grow 7%
Market research firm Technology Marketing Group of Des Plaines, IL, reported this month that nuclear medicine procedure volume climbed almost 7% in the U.S. in 1997, with the number of studies performed growing from 12.1 million in 1996 to 12.9 million
Market research firm Technology Marketing Group of Des Plaines, IL, reported this month that nuclear medicine procedure volume climbed almost 7% in the U.S. in 1997, with the number of studies performed growing from 12.1 million in 1996 to 12.9 million last year. Nuclear cardiology perfusion studies grew 17% over 1996, TMG reported. Cardiovascular studies make up 45% of overall nuclear medicine procedures, up from 38% in 1993.
TMG's data were based on surveys of more than 5600 nuclear medicine facilities, with 94% of the country's hospital nuclear medicine departments and 85% of independent sites responding. TMG reports that the U.S. gamma camera installed base stands at approximately 11,000 units, with more than half of those installed before 1993.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
